Spontaneous isolated dissection of the superior mesenteric artery (SID-SMA), without associated aortic dissection, is regarded as a clinically rare disease. This condition often manifests as acute abdomen.
diScUSSiOn
SID-SMA is a rare condition with an incidence of 0.06% based on a series of autopsy cases. [4] The first case of SID-SMA was reported by Bauersfeld in 1947. [5] With the increasing use of contrast-enhanced CT, a growing number of cases with SID-SMA have been reported in recent years. Usually, the entry point of an SMA dissection starts at 1.5-3 cm from the ostia because this is the zone where the relatively fixed retropancreatic SMA becomes mobile at the mesenteric root. Local shear stress induced by the pancreas at this zone has been postulated as one of the accepted hypotheses for SMA dissection. [6] High blood pressure, smoking, and atherosclerosis have been considered the main risk factors for SID-SMA.
Spontaneous isolated dissection of the superior mesenteric artery (SID-SMA) is a rare condition often presenting with vague signs and symptoms. Although the disease entity is rare, the potential for morbidity and mortality is high. Computed tomographic angiography is the preferred imaging modality for identification of SID-SMA. It may be managed by conservative, surgical, or endovascular treatment based on clinical presentation, but there is no general consensus regarding the treatment strategy. Here, we describe a case of SID of SMA treated successfully with percutaneous endovascular stent placement.
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Hence, blood pressure control is very important in reducing the distal progression of the SMA dissection and to prevent rupture. [7, 8] Sakamoto et al. [9] and subsequently Yun et al. [10] classified SID-SMA based on angiographic appearance as Type I -patent true and false lumens with visible entry and re-entry sites; Type IIa -patent true and false lumens with visible entry but no visible re-entry (blind pouch of false lumen); Type IIb -patent true lumen but thrombosed false lumen without visible re-entry which usually causes true luminal narrowing; and Type III -confirmed SMA dissection with occluded true and false lumens [ Figure 5 ].
SMA dissection may be completely asymptomatic or present as acute abdomen. In cases of chronic dissection with a compromised true lumen, patients may present with symptoms of postprandial pain and weight loss. [11] Rupture of the dissected SMA leads to hemorrhagic shock and even death. Due to the disease rarity, a high index of clinical suspicion is needed for diagnosis and treatment. [12, 13] CT angiography (CTA) is the investigation of choice to confirm the clinical suspicion, locate the entry point, and delineate the extension of the dissection. CTA may serve as a guide to decide on the treatment modality, conservative or operative. [14] Most patients with SID-SMA may experience a self-limited course, but it is also potentially fatal because of major complications such as the rupture of the dissection or secondary intestinal ischemia and infarction. [15] Treatment options include blood pressure control, antiplatelet therapy, anticoagulation, endovascular stenting, and surgical repair. [16, 17] Treatment objectives in SID-SMA are to limit the extension of dissection, to preserve the blood flow distally through the true lumen, and to prevent the rupture of the SMA, which can be achieved by the thrombosis and obliteration of the false lumen. [18] To date, there are no consensus guidelines regarding the best management of SID-SMA due to rarity of cases. [19] [20] [21] Endovascular stent placement in the management of SID-SMA was first described by Leung et al. [22] Many clinical reports claim endovascular stent placement as efficacious providing immediate symptomatic improvement by obliterating the false lumen and increasing blood flow into the small intestine and preventing further progression of the SMA dissection. [23] [24] [25] [26] [27] [28] [29] Limitations to endovascular treatment of SID-SMA are occasional difficulty to find the entry site of SMA dissection. Moreover, the long-term results, such as the risk of restenosis and reocclusion of the stented segments, have yet to be determined.
In our patient, endovascular stent placement was performed as the initial treatment of choice attributing to its benefit of rapid relief of symptoms.
cOnclUSiOn
Endovascular stent placement is a safe alternative to surgery or uncertain observation in the treatment armamentarium of SID-SMA. Endovascular stenting may be preferred in patients with SID-SMA without peritoneal signs for whom initial conservative treatment has failed. Long-term follow-up is necessary for evaluating the effectiveness of endovascular intervention.
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